Cargando…

Non-Motor Symptoms in Patients with Parkinson’s Disease – Correlations with Inflammatory Cytokines in Serum

BACKGROUND: Parkinson’s Disease (PD) is the second most common neurodegenerative disorder of the central nervous system. Motor symptoms are the focus of pharmacotherapy, yet non-motor features of the disease (e.g. fatigue, mood disturbances, sleep disturbances and symptoms of anxiety) are both commo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lindqvist, Daniel, Kaufman, Eli, Brundin, Lena, Hall, Sara, Surova, Yulia, Hansson, Oskar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474801/ https://www.ncbi.nlm.nih.gov/pubmed/23082161 http://dx.doi.org/10.1371/journal.pone.0047387

Ejemplares similares

Proinflammatory Cytokines Are Elevated in Serum of Patients with Multiple System Atrophy
por: Kaufman, Eli, et al.
Publicado: (2013)

Cerebrospinal fluid concentrations of inflammatory markers in Parkinson’s disease and atypical parkinsonian disorders
por: Hall, Sara, et al.
Publicado: (2018)

Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease
por: Hall, Sara, et al.
Publicado: (2016)

The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer’s but Not Parkinson’s Disease or Dementia with Lewy Bodies
por: Wennström, Malin, et al.
Publicado: (2015)

Alteration of putaminal fractional anisotropy in Parkinson’s disease: a longitudinal diffusion kurtosis imaging study
por: Surova, Yulia, et al.
Publicado: (2018)

Alterations of Diffusion Kurtosis and Neurite Density Measures in Deep Grey Matter and White Matter in Parkinson’s Disease
por: Surova, Yulia, et al.
Publicado: (2016)

Peripheral inflammatory cytokines and motor symptoms in persons with Parkinson's disease
por: Diaz, K., et al.
Publicado: (2022)

Serum inflammatory cytokines levels and the correlation analyses in Parkinson’s disease
por: Fu, Jiajia, et al.
Publicado: (2023)

Mapping of apparent susceptibility yields promising diagnostic separation of progressive supranuclear palsy from other causes of parkinsonism
por: Sjöström, Henrik, et al.
Publicado: (2019)

Low CSF Levels of Both α-Synuclein and the α-Synuclein Cleaving Enzyme Neurosin in Patients with Synucleinopathy
por: Wennström, Malin, et al.
Publicado: (2013)

Serum short-chain fatty acids and its correlation with motor and non-motor symptoms in Parkinson’s disease patients
por: Wu, Gang, et al.
Publicado: (2022)

Disease-specific structural changes in thalamus and dentatorubrothalamic tract in progressive supranuclear palsy
por: Surova, Yulia, et al.
Publicado: (2015)

Motor cortical plasticity and its correlation with motor symptoms in Parkinson's disease
por: Moriyasu, Shotaro, et al.
Publicado: (2022)

Serum Fatty Acids Are Correlated with Inflammatory Cytokines in Ulcerative Colitis
por: Wiese, Dawn M., et al.
Publicado: (2016)

Tryptophan Metabolites Are Associated With Symptoms and Nigral Pathology in Parkinson's Disease
por: Heilman, Patrick L., et al.
Publicado: (2020)

A Systematic Review of Neurofeedback for the Management of Motor Symptoms in Parkinson’s Disease
por: Anil, Krithika, et al.
Publicado: (2021)

Peripheral Inflammatory Cytokine Signature Mirrors Motor Deficits in Mucolipidosis IV
por: Misko, Albert L., et al.
Publicado: (2022)

Assessment of Global and Regional Diffusion Changes along White Matter Tracts in Parkinsonian Disorders by MR Tractography
por: Surova, Yulia, et al.
Publicado: (2013)

Pro-Inflammatory Cytokines Reduce the Proliferation of NG2 Cells and Increase Shedding of NG2 In Vivo and In Vitro
por: Wennström, Malin, et al.
Publicado: (2014)

Effects of nordic walking exercise on gait, motor/non-motor symptoms, and serum brain-derived neurotrophic factor in individuals with Parkinson's disease
por: Harro, Cathy C., et al.
Publicado: (2022)

Exendin-4 Treatment Improves LPS-Induced Depressive-Like Behavior Without Affecting Pro-Inflammatory Cytokines
por: Ventorp, Filip, et al.
Publicado: (2017)

Increased CSF biomarkers of angiogenesis in Parkinson disease
por: Janelidze, Shorena, et al.
Publicado: (2015)

Seborrheic Dermatitis Is Related to Motor Symptoms in Parkinson’s Disease
por: Tomic, Svetlana, et al.
Publicado: (2022)

Cytokines and tryptophan metabolites can predict depressive symptoms in pregnancy
por: Sha, Qiong, et al.
Publicado: (2022)

Plasma IL-6 and IL-17A Correlate with Severity of Motor and Non-Motor Symptoms in Parkinson’s Disease
por: Green, Holly F., et al.
Publicado: (2019)

Cerebral blood flow and cerebrovascular reactivity correlate with severity of motor symptoms in Parkinson’s disease
por: Pelizzari, Laura, et al.
Publicado: (2019)

Staging Parkinson's Disease Combining Motor and Nonmotor Symptoms Correlates with Disability and Quality of Life
por: Santos García, D., et al.
Publicado: (2021)

Subthalamic beta bursts correlate with dopamine-dependent motor symptoms in 106 Parkinson’s patients
por: Lofredi, Roxanne, et al.
Publicado: (2023)

Abnormal dynamic functional connectivity changes correlated with non-motor symptoms of Parkinson’s disease
por: Cao, Yuanyan, et al.
Publicado: (2023)

Treatment Options for Motor and Non-Motor Symptoms of Parkinson’s Disease
por: Church, Frank C.
Publicado: (2021)

Frequency of Non-motor Symptoms in Parkinson's Patients With Motor Fluctuations
por: Fernandes, Mariana, et al.
Publicado: (2021)

Editorial: Biomarkers of non-motor symptoms in Parkinson's disease and parkinsonisms
por: Filippi, Massimo, et al.
Publicado: (2023)

Cytokine-, Neurotrophin-, and Motor Rehabilitation-Induced Plasticity in Parkinson's Disease
por: Policastro, Gabriella, et al.
Publicado: (2020)

Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms
por: Xie, Aoji, et al.
Publicado: (2022)

Prodromal non-motor symptoms of Parkinson’s disease
por: Pellicano, Clelia, et al.
Publicado: (2007)

Non-Motor Off Symptoms in Parkinson's Disease
por: Cheon, Sang-Myung, et al.
Publicado: (2009)

Sleep and non-motor symptoms in Parkinson’s disease
por: Maass, Antonia, et al.
Publicado: (2013)

Spectrum of Non-Motor Symptoms in Parkinson's Disease
por: Kumaresan, Maithrayie, et al.
Publicado: (2021)

Is the Enzyme ACMSD a Novel Therapeutic Target in Parkinson’s Disease?
por: Thirtamara-Rajamani, Keerthi, et al.
Publicado: (2017)

Correlation of Decreased Serum Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide Levels With Non-motor Symptoms in Patients With Parkinson’s Disease
por: Hu, Shiyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_af6hmprc0a9a6pqb2dqnqsbu9c